Orlistat CAS: 96829-58-2
-
Post Date:
Mar 06,2018
-
Expiry Date:
Mar 06,2019
-
Detailed Description:
Cas No. :96829-58-2
Quantity: 1Kilograms
Specs:bodybuilding/ healthy care
Price:1 USD Kilograms
Payment Method: T/T Western union Moneygram
CAS: 96829-58-2
Synonyms: N-FORMYL-L-LEUCINE (1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYL ESTER;;(-)-Tetrahydrolipstatin(EquivalentToOrlistat);Orlipastat
MF: C29H53NO5
MW: 495.73
Assay: 99%
Appearance: White powder
Dosage:
Usual Adult Dose for Obesity:
120 mg orally three times a day with each main meal containing fat. The dose may be taken during the meal or within 1 hour of completing the meal.
Usual Pediatric Dose for Obesity:
12 years or older:
120 mg orally three times a day with each main meal containing fat. The dose may be taken during the meal or within 1 hour of completing the meal.
Description:
Orlistat is a drug designed to treat obesity. It is marketed as a prescription drug under the trade name Xenical by Roche in most countries, and is sold over-the-counter as Alli[2] by GlaxoSmithKline in the United Kingdom and the United States.[3] Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.
-
CAS Registry Number:
96829-58-2
-
Synonyms:
;(S)-2-FORMYLAMINO-4-METHYL-PENTANOIC ACID (S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYL ESTER;RO-18-0647;N-FORMYL-L-LEUCINE (1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYL ESTER;XENICAL;(-)-Tetrahydrolipstatin;Orlipastat;(1S)-1-{[(2R,3S)-3-hexyl-4-oxooxetan-2-yl]methyl}dodecyl N-formyl-D-leucinate;[(1S)-1-[[(2S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate;
-
Molecular Formula:
C29H53NO5
-
Molecular Weight:
495.7348
-
Molecular Structure:
-
Company:
Wuhan Hezhong Bio-Chemical Manufature Co.,Ltd
[ China ]
-
Contact:
Laura
-
Tel:
18872220713
-
Fax:
86-27-88048077
-
Email:
uoyyphar@ycphar.com
Inquiry